Related Experiment Video
Updated: Mar 23, 2026

06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
20.1K
Incident reporting to BfArM - regulatory framework, results and challenges
Biomedizinische Technik. Biomedical Engineering
|March 31, 2016
Summary
Manufacturers must ensure medical device safety and performance, reporting incidents to authorities like the Federal Institute for Drugs and Medical Devices (BfArM) for risk assessment. This article details the German regulatory framework and BfArM
Area of Science:
- Medical device technology and regulatory science.
- Public health and patient safety.
- Risk management in healthcare.
Background:
- Medical devices are a rapidly evolving technological field with significant economic impact.
- Manufacturers are legally required to ensure device safety and performance before market release.
- Critical incidents necessitate reporting to regulatory authorities for risk assessment.
Purpose of the Study:
- To describe the German regulatory framework for medical devices.
- To outline the responsibilities of the Federal Institute for Drugs and Medical Devices (BfArM).
- To present findings on prospective risk identification and application safety research.
Main Methods:
- Analysis of the German regulatory landscape for medical devices.
- Review of tasks and research initiatives of the BfArM.
- Failure mode and root cause analyses of reported medical device incident data.
Main Results:
- Description of the German regulatory framework and BfArM's role in medical device oversight.
- Presentation of research on prospective risk identification and application safety.
- Analysis of incident data, including cases where root-cause analysis was not possible.
Conclusions:
- The German regulatory system mandates rigorous risk assessment and incident reporting for medical devices.
- The BfArM plays a crucial role in ensuring medical device safety through regulatory oversight and research.
- Future challenges in risk assessment for increasingly complex medical devices require ongoing attention.
